|
Sign In to gain access to subscriptions and/or personal tools.
|
Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and Medicine
David Meltzer, MD, PhD
Magnus Johannesson, PhD
A key recommendation of the recent Panel on Cost-Effectiveness in Health and Med icine was that cost-effectiveness analyses be carried out from a societal perspective. The authors show that two of the Panel's recommendations concerning costs are not consistent with a societal perspective, and how to correct those inconsistencies. In its recommendations concerning costs resulting from morbidity, the Panel advises ex cluding lost income from costs in the belief that individuals take income changes into account when they respond to the quality-of-life questions that are used to calculate quality-adjusted life years (QALYs). It is shown that even if individuals do consider income changes in responding to these quality-of-life questions, this recommendation would seriously underestimate production losses due to morbidity, since individuals do not bear a major part of lost production. In its recommendations concerning costs resulting from mortality, the Panel does not require that health care costs for "unre lated" illness and non-health care consumption and production during added life years be included in the Reference Case. It is shown that omitting these costs will seriously distort comparisons of programs at different ages and favor programs that extend life over those that improve quality of life. This can be corrected by including total con sumption minus production in added life-years among costs. Key words: cost-effec tiveness analysis; societal perspective; public policy; resource allocation; Panel on Cost-Effectiveness in Health and Medicine. (Med Decis Making 1999; 19:371-377)
Medical Decision Making, Vol. 19, No. 4,
371-377 (1999)
DOI: 10.1177/0272989X9901900401
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
W. B. F. Brouwer, S. Grootenboer, and P. Sendi
The Incorporation of Income and Leisure in Health State Valuations When the Measure Is Silent: An Empirical Inquiry into the Sound of Silence
Med Decis Making,
July 1, 2009;
29(4):
503 - 512.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. H.-V. ROIJEN, A. VAN STRATEN, M. AL, F. RUTTEN, and M. DONKER
Cost-utility of brief psychological treatment for depression and anxiety
The British Journal of Psychiatry,
April 1, 2006;
188(4):
323 - 329.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Noyes, A. W. Dick, R. G. Holloway, and Parkinson Study Group
Pramipexole v. Levodopa as Initial Treatment for Parkinson's Disease: A Randomized Clinical-Economic Trial
Med Decis Making,
October 1, 2004;
24(5):
472 - 485.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. Sendi
Cost-effectiveness of a heart failure management program from the societal perspective?
J. Am. Coll. Cardiol.,
May 21, 2003;
41(10):
1850 - 1850.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Hirth, M. E. Chernew, E. Miller, A. M. Fendrick, and W. G. Weissert
Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard
Med Decis Making,
July 1, 2000;
20(3):
332 - 342.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. M. Garber
* Realistic Rigor in Cost-Effectiveness Methods
Med Decis Making,
October 1, 1999;
19(4):
378 - 379.
[PDF]
|
|
|
|
|
|
|
L. B. Russell
* Improving the Panel's Recommendations
Med Decis Making,
October 1, 1999;
19(4):
379 - 380.
[PDF]
|
|
|
|
|
|
|
M. C. Weinstein
* Theoretically Correct Cost-Effectiveness Analysis
Med Decis Making,
October 1, 1999;
19(4):
381 - 382.
[PDF]
|
|
|
|
|
